Literature DB >> 33436302

Xeroderma Pigmentosum: A Model for Human Premature Aging.

Elizabeth R H Rizza1, John J DiGiovanna1, Sikandar G Khan1, Deborah Tamura1, Jack D Jeskey2, Kenneth H Kraemer3.   

Abstract

Aging results from intrinsic changes (chronologic) and damage from external exposures (extrinsic) on the human body. The skin is ideal to visually differentiate their unique features. Inherited diseases of DNA repair, such as xeroderma pigmentosum (XP), provide an excellent model for human aging due to the accelerated accumulation of DNA damage. Poikiloderma, atypical lentigines, and skin cancers, the primary cutaneous features of XP, occur in the general population but at a much older age. Patients with XP also exhibit ocular changes secondary to premature photoaging, including ocular surface tumors and pterygium. Internal manifestations of premature aging, including peripheral neuropathy, progressive sensorineural hearing loss, and neurodegeneration, are reported in 25% of patients with XP. Internal malignancies, such as lung cancer, CNS tumors, and leukemia and/or lymphoma, occur at a younger age in patients with XP, as do thyroid nodules. Premature ovarian failure is overrepresented among females with XP, occurring 20 years earlier than in the general population. Taken together, these clinical findings highlight the importance of DNA repair in maintaining genomic integrity. XP is a unique model of human premature aging, which is revealing new insights into aging mechanisms.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33436302      PMCID: PMC7987754          DOI: 10.1016/j.jid.2020.11.012

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  114 in total

Review 1.  DNA damage mediated transcription arrest: Step back to go forward.

Authors:  Leon Mullenders
Journal:  DNA Repair (Amst)       Date:  2015-09-10

2.  The oxidative DNA lesions 8,5'-cyclopurines accumulate with aging in a tissue-specific manner.

Authors:  Jin Wang; Cheryl L Clauson; Paul D Robbins; Laura J Niedernhofer; Yinsheng Wang
Journal:  Aging Cell       Date:  2012-05-22       Impact factor: 9.304

Review 3.  Physiological consequences of defects in ERCC1-XPF DNA repair endonuclease.

Authors:  Siobhán Q Gregg; Andria Rasile Robinson; Laura J Niedernhofer
Journal:  DNA Repair (Amst)       Date:  2011-05-25

4.  Xeroderma pigmentosum. Clinical and laboratory investigation of its basic defect.

Authors:  W B Reed; B Landing; G Sugarman; J E Cleaver; J Melnyk
Journal:  JAMA       Date:  1969-03-17       Impact factor: 56.272

5.  Nucleotide excision repair proteins rapidly accumulate but fail to persist in human XP-E (DDB2 mutant) cells.

Authors:  Kyu-Seon Oh; Kyoko Imoto; Steffen Emmert; Deborah Tamura; John J DiGiovanna; Kenneth H Kraemer
Journal:  Photochem Photobiol       Date:  2011-03-09       Impact factor: 3.421

6.  Oxidative stress in cancer prone xeroderma pigmentosum fibroblasts. Real-time and single cell monitoring of superoxide and nitric oxide production with microelectrodes.

Authors:  Stéphane Arbault; Neso Sojic; Delphine Bruce; Christian Amatore; Alain Sarasin; Monique Vuillaume
Journal:  Carcinogenesis       Date:  2003-12-19       Impact factor: 4.944

7.  Mutation frequencies and spectra in DNA polymerase eta-deficient mice.

Authors:  Rita A Busuttil; Qingcong Lin; Peter J Stambrook; Raju Kucherlapati; Jan Vijg
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

8.  Comprehensive Assessment of Oxidatively Induced Modifications of DNA in a Rat Model of Human Wilson's Disease.

Authors:  Yang Yu; Candace R Guerrero; Shuo Liu; Nicholas J Amato; Yogeshwar Sharma; Sanjeev Gupta; Yinsheng Wang
Journal:  Mol Cell Proteomics       Date:  2015-09-11       Impact factor: 5.911

9.  XPC is an RNA polymerase II cofactor recruiting ATAC to promoters by interacting with E2F1.

Authors:  B Bidon; I Iltis; M Semer; Z Nagy; A Larnicol; A Cribier; M Benkirane; F Coin; J-M Egly; N Le May
Journal:  Nat Commun       Date:  2018-07-04       Impact factor: 14.919

10.  Mouse SLX4 is a tumor suppressor that stimulates the activity of the nuclease XPF-ERCC1 in DNA crosslink repair.

Authors:  Michael R G Hodskinson; Jan Silhan; Gerry P Crossan; Juan I Garaycoechea; Shivam Mukherjee; Christopher M Johnson; Orlando D Schärer; Ketan J Patel
Journal:  Mol Cell       Date:  2014-04-10       Impact factor: 17.970

View more
  7 in total

Review 1.  Genome Integrity and Neurological Disease.

Authors:  Elle E M Scheijen; David M Wilson
Journal:  Int J Mol Sci       Date:  2022-04-08       Impact factor: 6.208

Review 2.  Hypochlorous Acid: From Innate Immune Factor and Environmental Toxicant to Chemopreventive Agent Targeting Solar UV-Induced Skin Cancer.

Authors:  Jeremy A Snell; Jana Jandova; Georg T Wondrak
Journal:  Front Oncol       Date:  2022-04-29       Impact factor: 5.738

Review 3.  Mutations Involved in Premature-Ageing Syndromes.

Authors:  Fabio Coppedè
Journal:  Appl Clin Genet       Date:  2021-06-02

Review 4.  Genotoxic Damage During Brain Development Presages Prototypical Neurodegenerative Disease.

Authors:  Glen E Kisby; Peter S Spencer
Journal:  Front Neurosci       Date:  2021-12-02       Impact factor: 4.677

Review 5.  Human Variation in DNA Repair, Immune Function, and Cancer Risk.

Authors:  Ana Cheong; Zachary D Nagel
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

6.  Inflammatory landscape in Xeroderma pigmentosum patients with cutaneous melanoma.

Authors:  Asma Chikhaoui; Meriem Jones; Tadeja Režen; Melika Ben Ahmed; Chokri Naouali; Radovan Komel; Mohamed Zghal; Samir Boubaker; Sonia Abdelhak; Houda Yacoub-Youssef
Journal:  Sci Rep       Date:  2022-08-16       Impact factor: 4.996

Review 7.  The Impact of the Circadian Clock on Skin Physiology and Cancer Development.

Authors:  Janet E Lubov; William Cvammen; Michael G Kemp
Journal:  Int J Mol Sci       Date:  2021-06-06       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.